Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | EDNRA | P25101 | 1/20 | 0.68 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.68 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.68 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 5/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | PPIA | P62937 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL326633 | 0.83 | ALDH1A1 (0.71) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| SCHEMBL3066836 | 0.82 | LMNA (0.79) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| Hydrochloric Acid SCHEMBL27575105 | 0.82 | ALDH1A1 (0.69) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| SCHEMBL6312978 | 0.82 | ALDH1A1 (0.57) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| Sulfathiazole SCHEMBL11626630 | 0.81 | ALDH1A1 (0.94) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| SCHEMBL13180843 | 0.81 | ALDH1A1 (0.72) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| Sulfathiazole SCHEMBL30130508 | 0.81 | ALDH1A1 (1.00) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| SCHEMBL184078 | 0.81 | ALDH1A1 (0.72) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| SCHEMBL183995 | 0.81 | ALDH1A1 (0.72) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 | |
| SCHEMBL1650814 | 0.81 | ALDH1A1 (0.72) | ALDH1A1LMNASMN1; SMN2KDM4ECYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2599480-A1 | Compounds for the treatment of influenza | Universität Innsbruck (AT) | 2013-06-05 | — | — | EP | claimed |
| US-4629790-A | Quinoxaline adducts useful as anthelmintics | ANGUS CHEMICAL COMPANY (US) | 1986-12-16 | — | — | US | claimed |
| US-4025622-A | ANTIBACTERIAL | Ogura, Haruo (JA) | 1977-05-24 | — | — | US | claimed |
| EP-2599480-A1 | Compounds for the treatment of influenza | Universität Innsbruck (AT) | 2013-06-05 | — | — | EP | disclosed |
| US-20100189685-A1 | Antiviral Drugs for Treatment or Prevention of Dengue Infection | SIGA TECHNOLOGIES, INC. | 2010-07-29 | — | — | US | disclosed |
| US-4025622-A | ANTIBACTERIAL | Ogura, Haruo (JA) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100189685-A1 | Antiviral Drugs for Treatment or Prevention of Dengue Infection | EIF2AK2, HAVCR2, SNRPE | ALDH1A1 2072/4885LMNA 3407/4885SMN1; SMN2 509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.